Alberton will be the 40th SPAC to IPO in 2018.
Thanks to a super accommodating SEC (for quickly turning around a recently amended S-1 this morning), Alberton Acquisition Corporation is now expected to price their $100 million broadly-focused SPAC tonight for trading Wednesday morning. Alberton is being led by Bin (Ben) Wang, as Chairman and CEO. Mr. Wang is currently a Managing Director of Eon Capital International Ltd, a Hong Kong-incorporated corporate advisory service company.
Alberton will be the 40th SPAC to price in 2018, six more than 2017’s 34 SPAC IPOs. However, post-pricing of Alberton, we’re fresh out of new SPACs. Hopefully, we’ll get some new and exciting product to look at before the end of the week.
Albertson Acquisition Corporation Summary of Terms:
- Focus: General / Broad
- Size: $100 million
- 100.0% held in trust ($10.00 per share)
- $10.00 Unit comprised of one Ordinary Share + 1 Right + 1 Warrant
- 1 Right for 1/10 of one Ordinary Share
- 1 Warrant for 1/2 of one Ordinary Share
- Warrant trigger: > $16.00
- 12 months to complete an acquisition + two 3-month extensions (18 months total)
- $1 million to be deposited in trust at each extension
- At-risk Capital: $3.0 million (300,000 Units at $10.00)
- Underwriter fees: 2.0% + 3.5% deferred
Chardan is sole book-running manager.
White and Williams LLP and Loeb & Loeb LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.
InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...
Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...
Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...
The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...
Pacifico Acquisition Corp. (NASDAQ:PAFO) disclosed this afternoon that its shareholders have approved its business combination with sustainable shipping company Caravelle during a special meeting held earlier today. At today’s special meeting, 6,194,813 shares voted by proxy or in person, representing 82.65% of the total outstanding shares. The business combination was overwhelmingly approved as it received a...